Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of UIC201601 and UIC201602 Co-administration in Healthy Male Volunteers
NCT05190133Phase 1Completed
- Sponsor
- Korea United Pharm Inc.
- Start
- May 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of atorvastatin and omega-3-acid triglycerides in dyslipidemia (2 arms), sponsored by Korea United Pharm Inc. Primary endpoints: Area Under the Curve at Steady State over Dosing Interval at Day 49 and Maximum Concentration at Steady State at Day 49. Started May 2016; status: completed.
02
Drugs
atorvastatinomega-3-acid triglycerides
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT05190133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05190133.